← Back to catalogue

BinaxNOW COVID-19 Ag Card

FDA UDI

Class N (US FDA UDI)

by Alere Scarborough, Inc.

Identity

Trade Name
BinaxNOW COVID-19 Ag Card FDA UDI
Generic Name
SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical FDA UDI
Device Name
The BinaxNOW COVID-19 Ag Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 from individuals who are suspected of COVID-19 by their healthcare provider. FDA UDI
Model / Reference
195-000 FDA UDI
Description
The BinaxNOW COVID-19 Ag Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 from individuals who are suspected of COVID-19 by their healthcare provider. FDA UDI

Identifiers

Primary DI / UDI-DI
10811877011290 FDA UDI
FDA Product Code
QKP FDA UDI
GMDN Term
SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
N FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical

BinaxNOW COVID-19 Ag Card by Alere Scarborough, Inc. — Class N — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI ad68c86c-7580-4445-9604-ad21a7a9a0bf 33 fields · synced May 30, 2026